Thailand Neurological Disorder Drugs Market (2025-2031) | Share, Competitive Landscape, Outlook, Forecast, Size & Revenue, Industry, Growth, Segmentation, Analysis, Companies, Value, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Neurological Disorder Drugs Market - Industry Life Cycle

3.4 Thailand Neurological Disorder Drugs Market - Porter's Five Forces

3.5 Thailand Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Thailand Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 Thailand Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Thailand Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 Thailand Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in Thailand

4.2.2 Growing awareness and diagnosis rates of neurological disorders

4.2.3 Technological advancements in drug development for neurological disorders

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval in Thailand

4.3.2 High costs associated with research and development of neurological disorder drugs

4.3.3 Limited access to healthcare services in certain regions of Thailand

6.1 Thailand Neurological Disorder Drugs Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.1.4 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.7 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F

6.1.8 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 Thailand Neurological Disorder Drugs Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.3 Thailand Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F

6.2.4 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F

6.2.5 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F

6.2.6 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 Thailand Neurological Disorder Drugs Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.4 Thailand Neurological Disorder Drugs Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.5 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.5 Thailand Neurological Disorder Drugs Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5.4 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.5 Thailand Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 Thailand Neurological Disorder Drugs Market Export to Major Countries

7.2 Thailand Neurological Disorder Drugs Market Imports from Major Countries

8.1 Number of clinical trials conducted for neurological disorder drugs in Thailand

8.2 Adoption rate of new neurological disorder drugs in the market

8.3 Rate of successful drug approvals for neurological disorders in Thailand

9.1 Thailand Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Thailand Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 Thailand Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Thailand Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 Thailand Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Thailand Neurological Disorder Drugs Market Revenue Share, By Companies, 2024

10.2 Thailand Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters